EULAR 2007 News

Single Dose of Denosumab Reduces Bone Erosion in RA
June 19, 2007
MRI and X-ray data show that a single dose of denosumab reduces progression of bone erosions in RA patients...

Immediate Switch From TNF-Inhibitors To Abatacept Safe in RA Patients
June 18, 2007
A washout is not needed when switching from a TNF-inhibitor to abatacept...

Swedish Study Concludes That Having at Least 3 Drinks a Week Halves RA Risk
June 16, 2007
The more alcohol a person consumes, the more one's risk of RA is reduced...

Certolizumab, First PEGylated TNF-Blocker, May Surpass Older Drugs in Efficacy, Safety
June 16, 2007
When used with methotrexate, certolizumab pegol (Cimzia) may move rheumatoid arthritis (RA) patients into remission more quickly than currently available TNF-blockers...

Long-Term, Repeated Use of Rituximab Is Safe in RA
June 16, 2007
A safety analysis of RA patients with long-term, repeated exposure to rituximab should go far toward relieving concerns over extended use...

First Phase III Tocilizumab Data Show Rapid Improvement in RA Disease Activity, Confirming Critical Role of IL-6
June 15, 2007
Results of the first phase III trial of tocilizumab show that the anti-IL-6 monoclonal combined with methotrexate produces fast, sustained improvements in RA signs and symptoms, including a notable number of DAS28 remissions...

Has the Increasing Use of Anti-TNF Drugs Led to a Rise in Cases of Drug-Induced Lupus? Study Says Yes
June 15, 2007
The increasing use of TNFα inhibitors to treat rheumatic, digestive, and cutaneous diseases has led to a corresponding rise in  the number of cases of drug-induced lupus...